Open AccessAbstract 394: LXR agonist N,N-dimethyl-3-β-hydroxy-cholenamide, DMHCA, reduces ErbB2-dependent tumorigenesis and immune tolerance in a conditional model of mammary fibrosis
Author(s) -
Robert I. Glazer,
Sheng Gao,
Hongyan Yuan,
Suman Ranjit,
Jin Lu,
Xun Lu,
Moshe Levi
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-394
Subject(s) - fibrosis , cancer research , medicine , immune system , tumor microenvironment , carcinogenesis , foxp3 , pathology , cancer , immunology